/****** Font Awesome ******/ /****** Collapsing Nested Menu Items | Code by Elegant Themes ******/
Slide background

ARTEMIS

BIO-

Support

 

Services for vaccines and antiviral drug companies

Services for vaccines and antiviral drug companies

WE ARE A CONTRACT RESEARCH ORGANIZATION (CRO) SPECIALIZED IN THE EVALUATION OF VIRAL VACCINES AND ANTIVIRAL THERAPEUTICS

OUR CLIENTS ARE COMPANIES THAT ARE IN THE VERY EARLY STAGE DEVELOPMENT OF VACCINES AND ANTIVIRALS FOR HUMANS AND ANIMALS

We Focus On Helping You:

We help you adopt a de-risking strategy to accelerate your vaccine development and licensing.

We also enable our customers to increase success in their exploration and development programs by providing extensive preclinical immunogenicity evaluation packages, efficacy data integrated with artificial intelligence.

Explore Our Services

Call Us

+31(0)30 635 5444
We love doing business with you!

Explore Our Services

Protein production & Vaccine preparation
  • We help you adopt a de-risking strategy to accelerate your product development and licensing. Our protein expression systems include Leishmania, as well as a diverse range of bacterial and mammalian transient expression systems. Recombinant protein-based vaccines can be prepared in the form of virus-like particles.

  • We develop a range of standardized and validated virological and serological assays, including quantitative PCR packages, ELISAs and biosensor-based assays. These assays are tailored made to the scope and objectives of your pre-clinical studies.
Assistance In Experimental Recombinant Protein Vaccine:

We assist you in the development of your experimental recombinant protein vaccine by:

  • Preparing the vaccine formulation to perform vaccination/challenge experiments in the appropriate animal model.

Explore Our Services

Vaccine Evaluation Services (In vitro & In vivo testing):
  • Vaccine Immunogenicity testing
  • Vaccine Efficacy
  • Vaccine Safety Testing

We assist and support your preclinical studies to assess your product immunogenicity, efficacy and safety.

In vitro testing

Our goal is to help you expand your antivirals and vaccines pipeline as efficient as possible. We can test the efficacy of candidate antiviral drugs and vaccines against a variety of viruses.

In vivo testing

We offer preclinical studies in the most common animal species, including mice, rats, rabbits, ferrets and monkeys. Explore Our Services

 

 

 

 

 

 

 

 

OUR UNIQUE FOCUS is on:

Arboviruses e.g: Zoonotic viruses e.g:Respiratory viruses e.g:Herpesviruses e.g:
- Dengue
- West Nile
- Japanese encephalitis
- Tick-borne encephalitis
- Yellow fever
- Zika
- Chikungunya
- Ross River
- Rabies
- Influenza
- MERS
- Respiratory syncytial virus
- Human Metapneumovirus
- Cytomegalovirus
- Epstein-Barr virus
Proven Expertise

We have ample expertise in virology, immunology and vaccinology, and participate as principal investigators and partners in several national, international and EU-funded projects. We can provide scientific advisory services for your antiviral and vaccine research program, product development plan and study design, and preparation of biomedical manuscripts and grant applications. Explore Our Services

We Focus On Helping You:

We help you adopt a de-risking strategy to accelerate your vaccine development and licensing.

We also enable our customers to increase success in their exploration and development programs by providing extensive preclinical immunogenicity evaluation packages, efficacy data integrated with artificial intelligence.

Explore Our Services

Call Us

+31(0)30 635 5444
We love doing business with you!

Explore Our Services

Protein production & Vaccine preparation
  • We help you adopt a de-risking strategy to accelerate your product development and licensing. Our protein expression systems include Leishmania, as well as a diverse range of bacterial and mammalian transient expression systems. Recombinant protein-based vaccines can be prepared in the form of virus-like particles.
  • We develop a range of standardized and validated virological and serological assays, including quantitative PCR packages, ELISAs and biosensor-based assays. These assays are tailored made to the scope and objectives of your pre-clinical studies.

Assistance In Experimental Recombinant Protein Vaccine:

We assist you in the development of your experimental recombinant protein vaccine by:

  • Preparing the vaccine formulation to perform vaccination/challenge experiments in the appropriate animal model.

Explore Our Services

Vaccine Evaluation Services (In vitro & In vivo testing):
  • Vaccine Immunogenicity testing
  • Vaccine Efficacy
  • Vaccine Safety Testing

We assist and support your preclinical studies to assess your product immunogenicity, efficacy and safety.

In vitro testing

Our goal is to help you expand your antivirals and vaccines pipeline as efficient as possible. We can test the efficacy of candidate antiviral drugs against a variety of viruses.

In vivo testing

We offer preclinical studies in the most common animal species, including mice, rats, rabbits, ferrets and monkeys. Explore Our Services OUR UNIQUE FOCUS is on Arboviruses such as:                                            

  • Dengue
  • West Nile
  • Japanese encephalitis
  • Tick-borne encephalitis
  • Yellow fever
  • Zika
  • Chikungunya
  • Ross River

Zoonotic viruses such as:

  • Rabies
  • Influenza
  • MERS

Respiratory viruses such as:

  • Respiratory syncytial virus
  • Human Metapneumovirus

Herpesviruses such as:

  • Cytomegalovirus
  • Epstein-Barr virus

Proven Expertise

We have ample expertise in virology, immunology and vaccinology, and participate as principal investigators and partners in several national, international and EU-funded projects. We can provide scientific advisory services for your antiviral and vaccine research program, product development plan and study design, and preparation of biomedical manuscripts and grant applications. Explore Our Services

BSL-2 and BSL-3 FACILITIES

Artemis has access to BSL-2 and BSL-3 laboratory and animal facilities, with an extensive collaborative network to conduct high-containment studies, and dedicated personnel to position ourselves as your independent advisor and partner in vaccine and antiviral evaluation.

 

OUR PARTICIPATION IN SEVERAL GRANTS:

Our participation in several grants

IM2PACT

A project to develop improved human models of the BBB. The aim is to find ways to get therapeutics effectively into the brain and to learn how the BBB is altered by disease.

DRIVE

A project aiming to develop a package of analytical tests to evaluate Immunogenicity and protective efficacy of vaccines. Within this project, we will develop a vaccine against dengue virus and apply the package of tests to evaluate the candidate vaccines.

Flunivac (FP)

For the development of a universal influenza virus vaccine that protects against multiple influenza strains.

FLUCOP (IMI)

For the development and standardization of assays for assessment of influenza vaccine correlates of protection.

IM2PACT

A project to develop improved human models of the BBB. The aim is to find ways to get therapeutics effectively into the brain and to learn how the BBB is altered by disease.

DRIVE

A project aiming to develop a package of analytical tests to evaluate Immunogenicity and protective efficacy of vaccines. Within this project, we will develop a vaccine against dengue virus and apply the package of tests to evaluate the candidate vaccines.

FLUNIVAC (FP)

For the development of a universal influenza virus vaccine that protects against multiple influenza strains.

FLUCOP (IMI)

For development and standardization of assays for assessment of influenza vaccine correlates of protection.

ARTEMIS BIO-SUPPORT

WHO WE ARE

Company

Artemis Bio-support is a private company that was established on 21st of December 2010. Artemis was founded to help vaccine companies to accelerate development of novel viral vaccines. Artemis Bio-support focuses mainly on R&D and early pre-clinical stages of vaccine development. The results of the private company provide no pecuniary reward (non-profit organization) and 100% is put back into our foundation, the Artemis One Health Research Foundation. The foundation is the only shareholder of the private company.

Mission Statement

To help companies accelerate development and licensing of safe and effective vaccines by offering customized immunogenicity packages. By providing extensive preclinical immunogenicity and efficacy data integrated with artificial intelligence.

Vision Statement

To become a strategic partner in the process of vaccine development to facilitate rapid access to safe and effective vaccines.

Values

Impactful, integrity, commitment, Teamwork.

  • Safety: We will not compromise on health, safety and security
  • Integrity: We hold ourselves to the highest moral and ethical principles
  • Quality: We deliver the highest quality in everything we do
  • Trust: One of our core values at Artemis is to treat each other like family.
  • Commitment: We are committed to helping you achieve your professional dreams.
  • Sustainability: We act responsibly, always considering our impact on the planet, people, and communities in which we operate.

ARTEMIS BIO-SUPPORT

Artemis Bio-support is a Contract Research Organization (CRO) specialized in the evaluation of viral vaccines and antiviral therapeutics.

 

SOCIAL MEDIA

 

                 SUPPORT

CONTACT US

Molengraaffsingel 10
2629 JD Delft
The Netherlands

+31 (0) 30 635 5444

info@artemis-biosupport.com

Mo-Fri: 9:00 AM - 7:00 PM (local time)

Chamber of Commerce number: 51502259